Symptomatic improvement in diabetic neuropathy after 12 months of therapy with zenarestat, an aldose reductase inhibitor

被引：0
|
作者：
Bril, V
Ng, E
Nwe, P
Gogov, S
Ngo, ML
Skandarajah, S
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2136
引用
收藏
页码：A518 / A519
页数：2
相关论文
共 50 条
  • [1] Zenarestat -: Treatment of diabetic neuropathy aldose reductase inhibitor
    不详
    DRUGS OF THE FUTURE, 2001, 26 (01) : 104 - 105
  • [2] The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats
    Shimoshige, Y
    Ikuma, K
    Yamamoto, T
    Takakura, S
    Kawamura, I
    Seki, J
    Mutoh, S
    Goto, T
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (11): : 1395 - 1399
  • [3] Effect of zenarestat, an aldose reductase inhibitor, on endoneurial blood flow in experimental diabetic neuropathy of rat
    Kihara, M
    Mitsui, Y
    Shioyama, M
    Hasegawa, T
    Takahashi, M
    Takakura, S
    Minoura, K
    Kawamura, I
    NEUROSCIENCE LETTERS, 2001, 310 (2-3) : 81 - 84
  • [4] Enzyme specificity and tissue distribution of zenarestat, an aldose reductase inhibitor, and its relevance in the use of zenarestat as a therapeutic agent against diabetic neuropathy
    Takakura, S
    Minoura, H
    Shimoshige, Y
    Minoura, K
    Kawamura, I
    Fujiwara, T
    Saitoh, T
    Shimojo, F
    Seki, J
    Goto, T
    DRUG DEVELOPMENT RESEARCH, 2001, 54 (01) : 27 - 34
  • [5] PHARMACOKINETICS OF ZENARESTAT, AN ALDOSE REDUCTASE INHIBITOR, IN MALE AND FEMALE DIABETIC RATS
    TANAKA, Y
    SAWAMOTO, T
    SUZUKI, A
    KIMURA, T
    DRUG METABOLISM AND DISPOSITION, 1993, 21 (04) : 677 - 681
  • [6] CLINICAL AND NEUROPHYSIOLOGICAL STUDIES WITH THE ALDOSE REDUCTASE INHIBITOR, SORBINIL, IN SYMPTOMATIC DIABETIC NEUROPATHY
    LEWIN, IG
    OBRIEN, IAD
    MORGAN, MH
    CORRALL, RJM
    DIABETOLOGIA, 1984, 26 (06) : 445 - 448
  • [7] ALDOSE REDUCTASE INHIBITOR (TOLRESTAT) THERAPY IN PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHY
    HARATI, Y
    NIAKAN, E
    COMSTOCK, JP
    LOGAN, C
    ANNALS OF NEUROLOGY, 1987, 22 (01) : 129 - 129
  • [8] TOXICOKINETICS OF ZENARESTAT, AN ALDOSE REDUCTASE INHIBITOR IN ANIMALS AND MAN
    TANAKA, Y
    SHIMOJYO, H
    HATA, T
    HASHIMOTO, M
    NOGUCHI, H
    XENOBIOTICA, 1994, 24 (05) : 461 - 471
  • [9] A MULTICENTER TRIAL OF THE ALDOSE-REDUCTASE INHIBITOR, TOLRESTAT, IN PATIENTS WITH SYMPTOMATIC DIABETIC NEUROPATHY
    BOULTON, AJM
    LEVIN, S
    COMSTOCK, J
    DIABETOLOGIA, 1990, 33 (07) : 431 - 437
  • [10] EFFECT OF THE ALDOSE REDUCTASE INHIBITOR, PONALRESTAT, ON DIABETIC NEUROPATHY
    GILL, JS
    WILLIAMS, G
    GHATEI, MA
    HETREED, AH
    MATHER, HM
    BLOOM, SR
    DIABETES & METABOLISM, 1990, 16 (04): : 296 - 302
12345